Tag erbb2 [54 articles] Export Sort

Recent papers classified by the tag erbb2.

Hide details

	Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase [My Copy] J Clin Oncol, Vol. 23, No. 11. (10 April 2005), pp. 2469-2476. by M. Carolina Gutierrez, Simone Detre, Stephen Johnston, et al.Syed K. Mohsin, Jiang Shou, D. Craig Allred, Rachel Schiff, C. Kent Osborne, Mitch Dowsett posted to tamoxifen review pathway p38 mapk her2 erbb2 breast_cancer by tonamswish on 2009-12-11 16:57:56 as along with 1 person jfr
	14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. [My Copy] Cancer cell, Vol. 16, No. 3. (8 September 2009), pp. 195-207. by Jing Lu, Hua Guo, Warapen Treekitkarnmongkol, et al.Ping Li, Jian Zhang, Bin Shi, Chen Ling, Xiaoyan Zhou, Tongzhen Chen, Paul J. Chiao, Xinhua Feng, Victoria L. Seewaldt, William J. Muller, Aysegul Sahin, Mien-Chie C. Hung, Dihua Yu posted to tgfb_smad_pathway invasive_breast_cancer erbb2 erbb emt breast_cancer breast 14-3-3zeta by tonamswish on 2009-11-10 21:39:37 as
	Amplification of a 280-kilobase core region at the ERBB2 locus leads to activation of two hypothetical proteins in breast cancer. [My Copy] The American journal of pathology, Vol. 163, No. 5. (November 2003), pp. 1979-1984. by Päivikki Kauraniemi, Tuula Kuukasjärvi, Guido Sauter, Anne Kallioniemi posted to erbb2_amplicon erbb2 breast by giovenko on 2009-10-12 15:56:31 as
	PI3K Inhibition Overcomes Trastuzumab Resistance: Blockade of ErbB2/ErbB3 Is Not Always Enough [My Copy] Cancer Cell, Vol. 15, No. 5. (05 May 2009), pp. 353-355. by Nancy E. Hynes, Julien H. Dey posted to erbb2 pi3k review by tonamswish on 2009-06-01 14:15:15 as
	Androgen Receptor Controls EGFR and ERBB2 Gene Expression at Different Levels in Prostate Cancer Cell Lines [My Copy] Cancer Res, Vol. 69, No. 7. (1 April 2009), pp. 2941-2949. by Jean-Christophe Pignon, Benjamin Koopmansch, Gregory Nolens, Laurence Delacroix, David Waltregny, Rosita Winkler posted to androgen-receptor egfr erbb2 prostate-cancer by DevilInPgh on 2009-04-02 20:55:35 as
	Specific protection against breast cancers by cyclin D1 ablation. [My Copy] Nature, Vol. 411, No. 6841. (28 June 2001), pp. 1017-1021. by Q. Yu, Y. Geng, P. Sicinski posted to breast cancer cyclind1 erbb2 myc ras wnt by catcremona on 2009-02-25 22:41:05 as
	The Neurofibromatosis 2 Protein, Merlin, Regulates Glial Cell Growth in an ErbB2- and Src-Dependent Manner [My Copy] Mol. Cell. Biol., Vol. 29, No. 6. (15 March 2009), pp. 1472-1486. by Sean S. Houshmandi, Ryan J. Emnett, Marco Giovannini, David H. Gutmann posted to davide erbb2 fak glia merlin nf2 src by catcremona on 2009-02-25 22:27:42 as
	Blockade of the erbB2 receptor induces cardiomyocyte death through mitochondrial- and reactive oxygen species-dependent pathways. [My Copy] The Journal of biological chemistry (18 November 2008) by Leo I I. Gordon, Michael A A. Burke, Amareshwar T K T. Singh, et al.Sheila Prachand, Elliot D D. Lieberman, Lin Sun, Tejaswitha Jairaj J. Naik, Sathyamangla V V. Naga Prasad, Hossein Ardehali posted to apoptosis cardiomyocyte cell death erbb2 gordon09pdf ischemia by paulschlesinger on 2009-01-21 17:48:51 as along with 1 person Zephyrus
	Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. [My Copy] Nature (12 November 2008) by Antoni Hurtado, Kelly A A. Holmes, Timothy R R. Geistlinger, et al.Iain R R. Hutcheson, Robert I I. Nicholson, Myles Brown, Jie Jiang, William J J. Howat, Simak Ali, Jason S S. Carroll posted to breast cancer er erbb2 tamoxifen by songpku to the group Roswell Cancer Crosstalk on 2008-11-21 15:53:03 as along with 2 people and 1 group Zephyrus jfr Breast Cancer Reading Club
	HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer [My Copy] British Journal of Cancer, Vol. aop, No. current. (21 November 2006) by P. R. Benusiglio, P. D. Pharoah, P. L. Smith, et al.F. Lesueur, D. Conroy, R. N. Luben, G. Dew, C. Jordan, A. Dunning, D. F. Easton, B. A. J. Ponder posted to breast_cancer epidemiology erbb2 genetic_epidemiology hapmap snp by pbenusiglio on 2007-10-19 09:10:21 as
	Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study [My Copy] Breast Cancer Res, Vol. 7, No. 2. (2005), pp. R204-R209. by Patrick Benusiglio, Fabienne Lesueur, Craig Luccarini, et al.Donald Conroy, Mitul Shah, Douglas Easton, Nick Day, Alison Dunning, Paul Pharoah, Bruce Ponder posted to breast_cancer epidemiology erbb2 genetic_epidemiology snp by pbenusiglio on 2007-10-16 10:46:08 as
	Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo. [My Copy] Cancer Res, Vol. 61, No. 24. (15 December 2001), pp. 8887-8895. by S. L. Moulder, F. M. Yakes, S. K. Muthuswamy, R. Bianco, J. F. Simpson, C. L. Arteaga posted to egfr erbb2 inactive_dimer iressa by pjasper on 2007-05-10 20:38:57 as
	ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells. [My Copy] Clin Cancer Res, Vol. 9, No. 4. (April 2003), pp. 1274-1283. by J. Anido, P. Matar, J. Albanell, et al.M. Guzmán, F. Rojo, J. Arribas, S. Averbuch, J. Baselga posted to egfr erbb2 erbb3 inactive_dimer iressa by pjasper on 2007-05-10 20:36:31 as along with 1 person brianb
	Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site. [My Copy] J Biol Chem, Vol. 272, No. 37. (12 September 1997), pp. 23247-23254. by C. L. Arteaga, T. T. Ramsey, L. K. Shawver, C. A. Guyer posted to egfr erbb2 inactive_dimer inhibitor by pjasper on 2007-05-10 20:34:56 as
	HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cells. [My Copy] Cancer Res, Vol. 65, No. 10. (15 May 2005), pp. 4253-4260. by A. Hirata, F. Hosoi, M. Miyagawa, et al.S. Ueda, S. Naito, T. Fujii, M. Kuwano, M. Ono posted to egfr erbb2 inhibitor iressa nsclc by pjasper on 2007-05-10 19:52:18 as along with 1 person js229
	The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis [My Copy] Oncogene, Vol. aop, No. current. by M. M. Moasser posted to erbb2 review by pjasper on 2007-05-08 21:00:53 as along with 1 person guhjy
	Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers. [My Copy] Mol Cancer Res, Vol. 5, No. 4. (April 2007), pp. 393-401. by M. Maegawa, K. Takeuchi, E. Funakoshi, et al.K. Kawasaki, K. Nishio, N. Shimizu, F. Ito posted to c225 egfr erbb2 erbb3 inhibitor nsclc by pjasper on 2007-05-08 20:50:27 as
	The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer. [My Copy] Bioorg Med Chem Lett (19 March 2007) by Blaise Lippa, Goss S S. Kauffman, Joel Arcari, et al.Tricia Kwan, Jinshan Chen, William Hungerford, Samit Bhattacharya, Xumiao Zhao, Courtney Williams, Jun Xiao, Leslie Pustilnik, Chunyan Su, James D D. Moyer, Ling Ma, Mary Campbell, Stefanus Steyn posted to erbb2 inhibitor by pjasper on 2007-05-08 20:46:17 as
	Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. [My Copy] Cancer Res, Vol. 67, No. 6. (15 March 2007), pp. 2420-2424. by M. Bentires-Alj, B. G. Neel posted to breast erbb2 phosphatase by pjasper on 2007-05-08 19:03:15 as along with 1 person klu
	HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors [My Copy] Breast Cancer Research, Vol. 9 (02 March 2007), 205. by Neil Spector, Wenle Xia, Iman El-Hariry, Yossi Yarden, Sarah Bacus posted to erbb2 inhibitor by pjasper on 2007-05-08 18:50:28 as along with 1 person klu
	The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR\|[sol]\|ERBB2 inhibitor HKI-272 [My Copy] Oncogene, Vol. aop, No. current. by Y. Minami, T. Shimamura, K. Shah, et al.T. Laframboise, K. A. Glatt, E. Liniker, C. L. Borgman, H. J. Haringsma, W. Feng, B. A. Weir, A. M. Lowell, J. C. Lee, J. Wolf, G. I. Shapiro, K. K. Wong, M. Meyerson, R. K. Thomas, , posted to erbb2 hki-272 inhibitor mutation by pjasper on 2007-05-08 18:31:24 as
	HER2 therapy. HER2 (ERBB2): functional diversity from structurally conserved building blocks [My Copy] Breast Cancer Research, Vol. 9 (22 January 2007), 202. by Ralf Landgraf posted to erbb2 inhibitor review by pjasper on 2007-05-08 18:26:54 as
	Erlotinib directly inhibits HER2 kinase activation and downstream signaling events in intact cells lacking epidermal growth factor receptor expression. [My Copy] Cancer Res, Vol. 67, No. 3. (1 February 2007), pp. 1228-1238. by G. Schaefer, L. Shao, K. Totpal, R. W. Akita posted to activation egfr erbb2 tarceva by pjasper on 2007-05-08 18:23:41 as along with 1 person klu
	Targeting HER2 in prostate cancer: where to next? [My Copy] J Clin Oncol, Vol. 25, No. 3. (20 January 2007), pp. 241-243. by D. B. Solit, N. Rosen posted to erbb2 prostate review by pjasper on 2007-05-08 18:22:22 as
	Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC). [My Copy] Eur J Cancer, Vol. 43, No. 4. (March 2007), pp. 725-735. by R. Giuliani, V. Durbecq, A. Di Leo, et al.M. Paesmans, D. Larsimont, J. Y. Leroy, M. Borms, A. Vindevoghel, G. Jerusalem, V. D'Hondt, L. Dirix, J. L. Canon, V. Richard, V. Cocquyt, F. Majois, M. Reginster, J. Demol, J. P. Kains, P. Delree, C. Keppens, C. Sotiriou, M. J. Piccart, F. Cardoso posted to activation amplification breast erbb2 herceptin by pjasper on 2007-05-08 18:19:42 as
	Modeling HER2 Effects on Cell Behavior from Mass Spectrometry Phosphotyrosine Data. [My Copy] PLoS Comput Biol, Vol. 3, No. 1. (5 January 2007) by Neil Kumar, Alejandro Wolf-Yadlin, Forest M M. White, Douglas A A. Lauffenburger posted to erbb2 massspec migration by pjasper on 2007-05-08 18:12:38 as along with 2 people jfr cdpwebadmin
	c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function [My Copy] Oncogene, Vol. aop, No. current. by R. C. Ishizawar, T. Miyake, S. J. Parsons, posted to dimerization erbb2 erbb3 src by pjasper on 2007-04-26 17:33:20 as
	A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions [My Copy] PNAS, Vol. 103, No. 50. (12 December 2006), pp. 19063-19068. by T. S. Wehrman, W. J. Raab, C. L. Casipit, R. Doyonnas, J. H. Pomerantz, H. M. Blau posted to erbb2 herceptin by pjasper on 2007-04-26 17:26:05 as along with 1 person yeastyboy
	Her2-targeted therapies in non-small cell lung cancer. [My Copy] Clin Cancer Res, Vol. 12, No. 14 Pt 2. (15 July 2006) by C. Swanton, A. Futreal, T. Eisen posted to erbb2 inhibitor nsclc review by pjasper on 2007-04-25 21:46:05 as
	HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors [My Copy] Cancer Cell, Vol. 10, No. 1. (July 2006), pp. 25-38. by S WANG,, A NARASANNA,, M PEREZTORRES,, et al.B XIANG,, F WU,, S YANG,, G CARPENTER,, A GAZDAR,, S MUTHUSWAMY,, C ARTEAGA, posted to activation erbb2 inhibitor mutation resistance by pjasper on 2007-04-25 21:37:42 as
	Non-small-cell lung cancer and Ba/F3 transformed cells harboring the ERBB2 G776insV_G/C mutation are sensitive to the dual-specific epidermal growth factor receptor and ERBB2 inhibitor HKI-272. [My Copy] Cancer Res, Vol. 66, No. 13. (1 July 2006), pp. 6487-6491. by T. Shimamura, H. Ji, Y. Minami, et al.R. K. Thomas, A. M. Lowell, K. Shah, H. Greulich, K. A. Glatt, M. Meyerson, G. I. Shapiro, K. K. Wong posted to erbb2 hki-272 mutant nsclc by pjasper on 2007-04-25 21:24:26 as
	Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells. [My Copy] Clin Cancer Res, Vol. 12, No. 13. (1 July 2006), pp. 4103-4111. by K. Erjala, M. Sundvall, T. T. Junttila, et al.N. Zhang, M. Savisalo, P. Mali, J. Kulmala, J. Pulkkinen, R. Grenman, K. Elenius posted to erbb2 erbb3 inhibitor iressa resistance by pjasper on 2007-04-25 21:06:38 as
	Phosphoproteomic analysis of Her2/neu signaling and inhibition. [My Copy] Proc Natl Acad Sci U S A, Vol. 103, No. 26. (27 June 2006), pp. 9773-9778. by R. Bose, H. Molina, A. S. Patterson, et al.J. K. Bitok, B. Periaswamy, J. S. Bader, A. Pandey, P. A. Cole posted to erbb2 genomics signaling by pjasper on 2007-04-25 20:48:03 as
	The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling. [My Copy] Am J Physiol Gastrointest Liver Physiol, Vol. 291, No. 1. (July 2006) by L. A. Scheving, L. Zhang, M. C. Stevenson, E. S. Kwak, W. E. Russell posted to erbb2 igf signaling by pjasper on 2007-04-25 20:41:35 as
	Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo [My Copy] International Journal of Urology, Vol. 13, No. 5. (May 2006), pp. 587-592. by A. Nagasaw, I. Joj, I. Mizokam, et al.I. Atsush, A. Koshid, I. Kiyosh, A. Yoshid, I. Se, O. Nait, O. Kenichir, I. Namik, O. Miki posted to erbb2 inhibitor novel by pjasper on 2007-04-25 20:39:35 as
	Effects of HER2 overexpression on cell signaling networks governing proliferation and migration [My Copy] Mol Syst Biol, Vol. 2 (3 October 2006) by Alejandro Wolf-Yadlin, Neil Kumar, Yi Zhang, et al.Sampsa Hautaniemi, Muhammad Zaman, Hyung-Do Kim, Viara Grantcharova, Douglas A. Lauffenburger, Forest M. White posted to erbb2 migration signaling by pjasper on 2007-04-25 20:32:43 as along with 3 people and 1 group jfr balabu cdppublications CDP
	Advances in targeting human epidermal growth factor receptor-2 signaling for cancer therapy. [My Copy] Clin Cancer Res, Vol. 12, No. 21. (1 November 2006), pp. 6326-6330. by F. Meric-Bernstam, M. C. Hung posted to erbb2 inhibitor review by pjasper on 2007-04-25 20:25:04 as
	Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis. [My Copy] British journal of cancer, Vol. 95, No. 11. (4 December 2006), pp. 1504-1513. by H. Yokoyama, Y. Ikehara, Y. Kodera, et al.S. Ikehara, Y. Yatabe, Y. Mochizuki, M. Koike, M. Fujiwara, A. Nakao, M. Tatematsu, H. Nakanishi posted to erbb2 iressa resistance by pjasper on 2007-04-25 20:22:54 as along with 2 people mat956 klu
	Compensatory increases in Her-2/neu activation in response to EGFR tyrosine kinase inhibition in colon cancer cell lines. [My Copy] J Surg Res, Vol. 136, No. 2. (December 2006), pp. 227-231. by P. A. Learn, N. Krishnegowda, J. Talamantez, M. S. Kahlenberg posted to color erbb2 inhibitor by pjasper on 2007-04-25 20:03:27 as
	Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1/HER2 homodimer and heterodimer signaling. [My Copy] Clin Cancer Res, Vol. 12, No. 20 Pt 1. (15 October 2006), pp. 6186-6193. by T. W. Wong, F. Y. Lee, C. Yu, et al.F. R. Luo, S. Oppenheimer, H. Zhang, R. A. Smykla, H. Mastalerz, B. E. Fink, J. T. Hunt, A. V. Gavai, G. D. Vite posted to bms-599626 egfr erbb2 inhibitor by pjasper on 2007-04-25 20:00:02 as
	Surface Plasmon Resonance Investigations of Human Epidermal Growth Factor Receptor 2 [My Copy] Applied Spectroscopy, Vol. 60, No. 9. (September 2006), pp. 994-1003. by Martin, V.S., Sullivan, et al. B.A., Walker, K., Hawk, H., Sullivan, B.P., Noe, L.J. posted to erbb2 inhibitor structure by pjasper on 2007-04-25 19:46:51 as
	Herceptin sensitizes ErbB2-overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 expression. [My Copy] Clin Cancer Res, Vol. 12, No. 3 Pt 1. (1 February 2006), pp. 845-853. by E. S. Henson, X. Hu, S. B. Gibson posted to breast erbb2 herceptin by pjasper on 2007-04-25 18:48:18 as
	Activation of ErbB2 by 2-methyl-1,4-naphthoquinone (menadione) in human keratinocytes: role of EGFR and protein tyrosine phosphatases. [My Copy] FEBS Lett, Vol. 580, No. 7. (20 March 2006), pp. 1859-1864. by J. I. Beier, C. von Montfort, H. Sies, L. O. Klotz posted to erbb2 phosphatase by pjasper on 2007-04-25 18:44:31 as
	Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4 [My Copy] Oncogene, Vol. aop, No. current. by A. J. Jackson-Fisher, G. Bellinger, E. Shum, et al.J. K. Duong, A. S. Perkins, M. Gassmann, W. Muller, Kent K. C. Lloyd, D. F. Stern posted to breast erbb2 erbb4 by pjasper on 2007-04-25 16:33:42 as
	Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. [My Copy] Nature clinical practice. Oncology, Vol. 3, No. 5. (01 May 2006), pp. 269-280. by Rita Nahta, Dihua Yu, Mien-Chie C. Hung, Gabriel N. Hortobagyi, Francisco J. Esteva posted to breast erbb2 herceptin resistance review by pjasper on 2007-04-25 16:26:57 as along with 2 people mat956 jfr
	High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor. [My Copy] Cancer Res, Vol. 65, No. 24. (15 December 2005), pp. 11478-11485. by N. Fujimoto, M. Wislez, J. Zhang, et al.K. Iwanaga, J. Dackor, A. E. Hanna, S. Kalyankrishna, D. D. Cody, R. E. Price, M. Sato, J. W. Shay, J. D. Minna, M. Peyton, X. Tang, E. Massarelli, R. Herbst, D. W. Threadgill, I. I. Wistuba, J. M. Kurie posted to erbb2 erbb3 iressa ligands by pjasper on 2007-04-19 19:42:05 as
	Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells. [My Copy] Cancer Res, Vol. 65, No. 23. (1 December 2005), pp. 11118-11128. by R. Nahta, L. X. Yuan, B. Zhang, R. Kobayashi, F. J. Esteva posted to breast erbb2 herceptin igf by pjasper on 2007-04-19 19:21:07 as
	2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth. [My Copy] Cancer, Vol. 104, No. 12. (15 December 2005), pp. 2701-2708. by N. Takai, A. Jain, N. Kawamata, et al.L. M. Popoviciu, J. W. Said, S. Whittaker, I. Miyakawa, D. B. Agus, H. P. Koeffler posted to 2c4 erbb2 inhibitor by pjasper on 2007-04-19 18:54:07 as along with 1 person brianb
	The c-Src tyrosine kinase associates with the catalytic domain of ErbB-2: implications for ErbB-2 mediated signaling and transformation [My Copy] Oncogene, Vol. aop, No. current. by Harold Kim, Richard Chan, David L. Dankort, et al.Dongmei Zuo, Monica Najoukas, Morag Park, William J. Muller, posted to erbb2 src by pjasper on 2007-04-18 21:16:42 as
	Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer [My Copy] Investigational New Drugs, Vol. 23, No. 5. (October 2005), pp. 391-409. by Christina Yeon, Mark Pegram posted to breast erbb2 herceptin review by pjasper on 2007-04-18 21:13:12 as

Note: You may cite this page as: http://www.citeulike.org/tag/erbb2

Result page: 1 2 Next

Sort by:
Order:	Default Ascending Descending
Empty fields:	Default First Last

inhibitor	16
breast	14
review	10
egfr	8
iressa	7
herceptin	6
resistance	6
cancer	5
erbb3	5
nsclc	5
breast_cancer	4
tamoxifen	4
activation	3
er	3
inactive_dimer	3
mutation	3
signaling	3
src	3
amplification	2
cardiomyocyte	2
epidemiology	2
genetic_epidemiology	2
hki-272	2
igf	2
migration	2
phosphatase	2
snp	2
tki	2
14-3-3zeta	1
2c4	1
androgen-receptor	1
apoptosis	1
bms-599626	1
c225	1
cell	1
color	1
cyclind1	1
davide	1
death	1
dimerization	1
emt	1
erbb	1
erbb2_amplicon	1
erbb4	1
fak	1
genomics	1
glia	1
gordon09pdf	1
hapmap	1
her2	1
inhibitors	1
internalization	1
invasive_breast_cancer	1
ischemia	1
ligands	1
mapk	1
massspec	1
merlin	1
mitochondria	1
mutant	1
myc	1
nf2	1
novel	1
p38	1
pathway	1
pi3k	1
prostate	1
prostate-cancer	1
ras	1
ros	1
structure	1
tarceva	1
tgfb_smad_pathway	1
thelist	1
wnt	1

Tag erbb2 [54 articles] Export Sort

Related Tags